✦ LIBER ✦

Cost not a barrier to use of vinorelbine in NSCLC

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost, not adherence, main barrier to ant

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Cost as a Barrier to Long-Acting Reversi

✍ Eisenberg, David; McNicholas, Colleen; Peipert, Jeffrey F. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 257 KB

Intravenous drug use: not a barrier to a

✍ H. Jafferbhoy; M.H. Miller; J.K. Dunbar; J. Tait; S. Mcleod; J.F. Dillon 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Histology classification is not a predic

✍ Trani, L.; Myerson, J.; Ashley, S.; Young, K.; Sheri, A.; Hubner, R.; Puglisi, M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 227 KB

A cost-effectiveness analysis of the use

✍ J.P. AuBuchon; B. Littenberg 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 515 KB

9054 Histology classification is not a p

✍ Trani, L.; Myerson, J.; Young, K.; Sheri, A.; Hubner, R.; Puglisi, M.; Popat, S. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB